相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
Alan T. Tang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Sean P. Polster et al.
NEUROSURGERY (2019)
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations
Romuald Girard et al.
TRANSLATIONAL STROKE RESEARCH (2018)
Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis
Lorna M. Gibson et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
Romuald Girard et al.
JOURNAL OF NEUROSURGERY (2017)
Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis
Bradley A. Gross et al.
JOURNAL OF NEUROSURGERY (2017)
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations
Alan T. Tang et al.
NATURE (2017)
Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
Amy Akers et al.
NEUROSURGERY (2017)
Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia
Michael C. Davis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults Mayo Clinic Study of Aging
Kelly D. Flemming et al.
JAMA NEUROLOGY (2017)
Degradation dynamics of microRNAs revealed by a novel pulse-chase approach
Matteo J. Marzi et al.
GENOME RESEARCH (2016)
Safety of Propranolol Therapy for Severe Infantile Hemangioma
Sorilla Prey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Prognosis of cerebral cavernomas: on to treatment decisions
Ale Algra et al.
LANCET NEUROLOGY (2016)
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data
Margaret A. Horne et al.
LANCET NEUROLOGY (2016)
Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage
Joseph M. Zabramski et al.
WORLD NEUROSURGERY (2016)
Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma
Graham M. Strub et al.
JCI INSIGHT (2016)
Vascular permeability in cerebral cavernous malformations
Abdul G. Mikati et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
C. Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Propranolol for Cerebral Cavernous Angiomatosis: A Magic Bullet
Irene Berti et al.
CLINICAL PEDIATRICS (2014)
Evaluation of Iron Content in Human Cerebral Cavernous Malformation Using Quantitative Susceptibility Mapping
Huan Tan et al.
INVESTIGATIVE RADIOLOGY (2014)
Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol
Juliette Miquel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Non-coding RNAs in cerebral endothelial pathophysiology: Emerging roles in stroke
Ke-Jie Yin et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Outcome after surgical or conservative management of cerebral cavernous malformations
Fiona Moultrie et al.
NEUROLOGY (2014)
Sample size calculations for pilot randomized trials: a confidence interval approach
Kim Cocks et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
EndMT contributes to the onset and progression of cerebral cavernous malformations
Luigi Maddaluno et al.
NATURE (2013)
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Beth A. Drolet et al.
PEDIATRICS (2013)
The role and interpretation of pilot studies in clinical research
Andrew C. Leon et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controls
Denise Josephina Johanna Hermans et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Propranolol Treatment for a Giant Infantile Brain Cavernoma
Maria Moschovi et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation
Chad W. Washington et al.
NEUROSURGICAL FOCUS (2010)
Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development
Yun He et al.
SCIENCE SIGNALING (2010)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
Axel Pagenstecher et al.
HUMAN MOLECULAR GENETICS (2009)
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
Amy L. Akers et al.
HUMAN MOLECULAR GENETICS (2009)
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis
Zoe Morris et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Hemorrhage From Cavernous Malformations of the Brain Definition and Reporting Standards
Rustam Al-Shahi Salman et al.
STROKE (2008)
Genetics of cavernous angiomas
Pierre Labouge et al.
LANCET NEUROLOGY (2007)
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
J Gault et al.
STROKE (2005)
分享论文
